已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Efficacy and acceptability of mobile application-delivered acceptance and commitment therapy for posttraumatic stress disorder in China: A randomized controlled trial

注意 接受和承诺疗法 心理健康 焦虑 萧条(经济学) 创伤后应激 随机对照试验 临床心理学 精神科 心理学 医学 干预(咨询) 内科学 宏观经济学 经济
作者
Chunxiao Zhao,Ziyi Zhao,Michael E. Levin,Lizu Lai,Congrong Shi,Jiawei Hu,Wenke Chen,Zhihong Ren
出处
期刊:Behaviour Research and Therapy [Elsevier BV]
卷期号:171: 104440-104440 被引量:10
标识
DOI:10.1016/j.brat.2023.104440
摘要

Due to the COVID-19 pandemic and its extensive effects, the incidence of posttraumatic stress disorder (PTSD) symptoms is rapidly increasing in China. This research aimed to assess the efficacy and acceptability of a mobile application delivering Acceptance and Commitment Therapy (ACT) in reducing PTSD symptoms. 221 Chinese individuals with elevated PTSD symptoms were randomly assigned to app-delivered ACT (ACT condition), app-delivered mindfulness (MI condition), or a waitlist (WL condition). Assessments were performed pre- and post-intervention. The results showed that participants in both the ACT and MI groups had significantly greater improvements across mental health outcomes compared to the WL group. No significant differences were observed between the ACT and MI groups except for psychological flexibility, which improved more in ACT than MI (d = -0.37). Compared to WL, the ACT group showed a greater improvement in PTSD symptoms (d = -0.79), anxiety (d = -0.62), depression (d = -0.51), posttraumatic growth (d = 0.46), and psychological flexibility (d = 0.76). The drop-out rates in the ACT and MI were 25.76% and 39.71%, respectively. Participants in the ACT condition reported medium program satisfaction. The study suggests app-delivered ACT is efficacious in reducing PTSD symptoms and improving overall mental health among Chinese adults.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小宋完成签到,获得积分10
2秒前
尊敬的凝丹完成签到 ,获得积分10
3秒前
4秒前
沉静的毛衣完成签到,获得积分10
4秒前
小龙锅发布了新的文献求助10
6秒前
chen完成签到 ,获得积分10
7秒前
shoolarli完成签到,获得积分10
9秒前
甜美千山完成签到 ,获得积分10
11秒前
温馨家园完成签到 ,获得积分10
14秒前
Ava应助Darlin采纳,获得10
14秒前
18秒前
18秒前
19秒前
壮观小懒虫完成签到,获得积分10
19秒前
20秒前
PHIL发布了新的文献求助10
21秒前
21秒前
21秒前
ProfYang发布了新的文献求助10
21秒前
21秒前
ProfYang发布了新的文献求助10
22秒前
23秒前
23秒前
ProfYang发布了新的文献求助10
24秒前
ProfYang发布了新的文献求助10
24秒前
24秒前
24秒前
24秒前
拼搏的冰绿完成签到 ,获得积分10
24秒前
ProfYang发布了新的文献求助10
24秒前
24秒前
25秒前
25秒前
25秒前
25秒前
25秒前
ProfYang发布了新的文献求助10
25秒前
25秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6165321
求助须知:如何正确求助?哪些是违规求助? 7992728
关于积分的说明 16620199
捐赠科研通 5271935
什么是DOI,文献DOI怎么找? 2812670
邀请新用户注册赠送积分活动 1792733
关于科研通互助平台的介绍 1658608